Rmc 6236 001 Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rmc 6236 001 trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rmc 6236 001 Trial Today - Breaking & Trending Today

Dr Johnson on the Efficacy of RMC-6236 in KRAS-Mutant NSCLC

Melissa L. Johnson, MD, discusses the preliminary efficacy findings from the phase 1 RMC-6236-001 trial in patients with non–small cell lung cancer harboring KRAS mutations and details the significance of these findings for patients within the KRAS G12X-mutant NSCLC population. ....

Melissal Johnson , Sarah Cannon Research Institute , Rmc 6236 001 Trial , Patients With Non Small Cell Lung Cancer , Kras G12x Mutant Nsclc ,

Phase 1 Data Support Further Investigation of RMC-6236 in KRAS-Mutant NSCLC

Kathryn C. Arbour, MD, discusses the unique mechanism of action of RMC-6236, the preliminary efficacy and safety findings for this agent in patients with KRAS-mutant NSCLC, and future directions for the RMC-6236-001 trial. ....

Memorial Sloan Kettering Cancer Center , New York , United States , Kathrync Arbour , Rmc 6236 , Patients With Kras Mutant Nsclc , Rmc 6236 001 Trial ,